Skip to main content
. 2004 Apr;1(2):182–188. doi: 10.1602/neurorx.1.2.182

TABLE 1.

Contributions of Valid Biomarkers to Clinical Research

Capabilities of Biomarkers
  • Delineation of events between exposure and disease

  • Establishment of dose-response

  • Identification of early events in the natural history

  • Identification of mechanisms by which exposure and disease are related

  • Reduction in misclassification of exposures or risk factors and disease

  • Establishment of variability and effect modification

  • Enhanced individual and group risk assessments

Modified from Schulte.9